Neurocognitive Outcomes over the First 3 Months after Chimeric Antigen Receptor T-Cell (CAR T) Therapy: Preliminary Findings from a Longitudinal Study

被引：0

作者：

Mayo, Samantha J. ^{[1
,2
]}

Edelstein, Kim ^{[2
]}

Bernstein, Lori ^{[2
]}

Coley, Tiana ^{[3
]}

Morrison, Stacey ^{[2
]}

Vijenthira, Abi ^{[3
]}

Maganti, Manjula ^{[4
]}

Kuruvilla, John ^{[3
]}

Crump, Michael ^{[3
]}

Bhella, Sita D. ^{[3
]}

Kridel, Robert ^{[3
]}

Kukreti, Vishal ^{[3
]}

Yang, Chloe ^{[3
]}

Alibhai, Shabbir M. H. ^{[2
]}

Chen, Christine ^{[3
]}

Prica, Anca ^{[3
]}

机构：

[1] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada

[2] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada

[3] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada

[4] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190650

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Brown, Christine E.
Alizadeh, Darya
Starr, Renate
Weng, Lihong
Wagner, Jamie R.
Naranjo, Araceli
Ostberg, Julie R.
Blanchard, M. Suzette
Kilpatrick, Julie
Simpson, Jennifer
Kurien, Anita
Priceman, Saul J.
Wang, Xiuli
Harshbarger, Todd L.
D'Apuzzo, Massimo
Ressler, Julie A.
Jensen, Michael C.
Barish, Michael E.
Chen, Mike
Portnow, Jana
Forman, Stephen J.
Badie, Behnam
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26): : 2561 - 2569
[32] Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
Verdun, Nicole
Marks, Peter
NEW ENGLAND JOURNAL OF MEDICINE, 2024,
[33] Optic neuropathy after chimeric antigen receptor T-cell therapy
Huang, Ching-Wen
Tsai, Cheng-Hong
Lin, Chao-Wen
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (05) : 1012 - 1013
[34] Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
不详
TRANSFUSIONSMEDIZIN, 2024, 14 (02) : 71 - 71
[35] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS
Kumar, P.
Wurster, S.
daSilva, T.
Hauser, P.
Neelapu, S. S.
Kontoyiannis, D.
CYTOTHERAPY, 2024, 26 (06) : S10 - S11
[36] Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma
Feldman, Lisa
Brown, Christine
Badie, Behnam
NEUROMOLECULAR MEDICINE, 2022, 24 (01) : 35 - 40
[37] Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma
Lisa Feldman
Christine Brown
Behnam Badie
NeuroMolecular Medicine, 2022, 24 : 35 - 40
[38] Chimeric Antigen Receptor T-Cell-Associated Cholangiopathy: First Reported Case of a Complication of Chimeric Antigen Receptor T-Cell Therapy
Huang, Albert Z.
Kim, Hyun Jae
Zhao, Billy
Owen, Daniel R.
Jain, Avni
Chahal, Daljeet
Yoshida, Eric M.
ACG CASE REPORTS JOURNAL, 2025, 12 (01)
[39] Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions
Wat, Jeanette
Barmettler, Sara
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 460 - 466
[40] COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy
Kampouri, Eleftheria
Hill, Joshua A.
Dioverti, Veronica
TRANSPLANT INFECTIOUS DISEASE, 2023, 25

← 1 2 3 4 5 →